Market revenue in 2020 | USD 6,147.4 million |
Market revenue in 2028 | USD 23,948.9 million |
Growth rate | 18.5% (CAGR from 2020 to 2028) |
Largest segment | (crispr)/cas9 |
Fastest growing segment | (CRISPR)/Cas9 |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
Key market players worldwide | Thermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.
(crispr)/cas9 was the largest segment with a revenue share of 42.9% in 2020. Horizon Databook has segmented the Japan mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.
Japan accounted for a significant share in Asia Pacific’s market in 2020, due to ongoing developments in the gene-editing space. For instance, in December 2020, Sanatech Seed, Japan, introduced genome-edited tomatoes for direct consumption. The Ministry of Health, Labour and Welfare approved the production and sale of this product.
This tomato was developed using CRISPR-Cas9 gene-editing technology. Such developments are expected to boost research in gene-edited plants, increasing the demand for mutation detection kits in the market. Furthermore, presence of key players in the market can further support its growth. For instance, Takara Bio, Inc., one of the market’s prominent players, is headquartered in Japan.
The company offers Guide-it Mutation Detection Kit that can detect mutations generated by engineered nucleases, such as CRISPR/Cas9, Transcription-activator-like Effector Nucleases (TALENs), or Zinc-finger Nucleases (ZFNs).
Horizon Databook provides a detailed overview of country-level data and insights on the Japan mutation detection kits in genome editing market , including forecasts for subscribers. This country databook contains high-level insights into Japan mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account